Prescription Drug Inflectra Recalled Nationwide for Manufacturing Quality Deviations
McKesson is recalling Inflectra (infliximab-dyyb) injectable drug due to manufacturing quality deviations. A batch intended for quarantine was inadvertently distributed to patients nationwide.
- Product
- INFLECTRA — INFLECTRA (INFLIXIMAB-DYYB)
- Category
- Drug
- Distribution
- Distributed nationwide